Trial
NCT00863330
Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Melanoma (Skin)
Intervention
Tumor Infiltrating Lymphocytes (TIL)
Why stopped
administrative decision- PI retired and treating physician left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-03